Top Markets
Coin of the day
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
株式のランク #4864
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
株価
$3.50
時価総額
$3.22B
変化(1日)
1.17%
変化(1年)
-50.77%
CN
取引 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

カテゴリー

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(300255)の配当利回りの履歴
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(銘柄コード: 300255)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(300255)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)